Top Stories4 weeks ago
Palvella Therapeutics Secures European Patent for QTORIN™
Palvella Therapeutics has successfully obtained a European patent for its innovative formulation, QTORIN™, which includes anhydrous compositions of rapamycin. This patent marks a significant milestone in...